MARKET IS OPEN
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

INCR — Intercure Ltd. Ordinary Shares

Nasdaq

Intercure Ltd. Ordinary Shares

CompareBack to Screener
$5.42
+0.05(+0.93%)
O
5.38
H
5.42
L
5.38
V
2.76K
⏱️ End-of-day dataAs of Oct 2, 2026

Chart

About INCR

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.

IndustryCommon Stock
SectorNot available
IPO DateJan 1, 2019
Employees285
Stock ExchangeNasdaq
Ticker SymbolINCR

Key Financial Statistics

Market Cap$81.32M
P/E RatioN/A
Dividend YieldNone
EPSN/A
BetaN/A
52-Week Range$0.68 - $6.10
52-Week Avg Volume51.2K
VWAP$5.40
Transactions82
Total Recorded Bars1,774 days